跳至主要内容
临床试验/CTRI/2025/07/090303
CTRI/2025/07/090303招募中2 期

Efficacy of Zaranbad (Curcuma zeodaria) in Primary Dysmenorrhoea: A Single Blind Randomized Controlled Trial.

State Takmeel-ut-Tib College and Hospital, Lucknow1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年7月14日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
40
试验地点
1
主要终点
Relief in intensity of pain during menstrual cycle

研究概览

简要总结

This is single blind randomised controlled trial for female  patients suffering from primary dysmenorrhoea in which efficacy of Zaranbad ( Curcuma zeodaria )  will be evaluated and also comparing the effets the mention drug  with standard drug mefenamic acid. Patients fulfilling inclusion criteria will be added to either test group or control group, patient will take research drug in form of capsule After the study duration effects of both test and control drugs will be compared.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 30.00 Year(s)(—)
性别
Female

入选标准

  • All unmarried and married women aged between 18 to 30 years of age with no pelvic pathology.
  • Regular painful menstrual cycle graded by V.A.S scale (score more than grade 3) and V.R.S scale (score more than 0).

排除标准

  • All unmarried and married women aged between 18 to 30 years of age with pelvic pathology.
  • Pregnant females.
  • Lactating Females.
  • Females taking O.C.P.

结局指标

主要结局

Relief in intensity of pain during menstrual cycle

时间窗: 2months

次要结局

  • Improvement in quality of life.(2 months)

研究者

发起方
State Takmeel-ut-Tib College and Hospital, Lucknow
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Ghazala Hashmi

State Takmeel-ut-Tib College and Hospital, Lucknow

研究点 (1)

Loading locations...

相似试验